- Home
- DDD vs ABEO Comparison
DDD vs ABEO Comparison
Compare DDD & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DDD | ABEO |
|---|---|---|
| Founded | 1986 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 274.6M | 280.2M |
| IPO Year | 2003 | 2005 |
Fundamental Metrics
Financial Performance| Metric | DDD | ABEO |
|---|---|---|
| Price | $2.15 | $5.37 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $4.75 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 2.4M | 1.3M |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 109.79 | ★ 165.16 |
| EPS | 0.19 | ★ 1.01 |
| Revenue | ★ $386,902,000.00 | $2,998,000.00 |
| Revenue This Year | $2.48 | $1,024.31 |
| Revenue Next Year | $4.10 | $145.42 |
| P/E Ratio | $10.68 | ★ $5.35 |
| Revenue Growth | N/A | ★ 258.18 |
| 52 Week Low | $1.48 | $4.00 |
| 52 Week High | $3.80 | $7.54 |
Technical Indicators
Market Signals| Indicator | DDD | ABEO |
|---|---|---|
| Relative Strength Index (RSI) | 58.07 | 65.36 |
| Support Level | $1.82 | $5.24 |
| Resistance Level | $2.18 | $5.62 |
| Average True Range (ATR) | 0.10 | 0.23 |
| MACD | 0.03 | 0.11 |
| Stochastic Oscillator | 92.41 | 94.65 |
Price Performance
Historical ComparisonAbout DDD 3D Systems Corporation
3D Systems Corp provide comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, manufacturing and applications engineering. Its solutions support applications in two key industry verticals: Healthcare Solutions provide surgical planning, implants, instrumentation, and medical education solutions to help medical device manufacturers and healthcare providers accelerate, and ultimately, transform healthcare, and Industrial Solutions which includes aerospace, defense, transportation and general manufacturing. The company operates in the Americas, EMEA, and APAC regions.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.